JPY 648.0
(1.41%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -1.13 Billion | -1.88 Billion | -16.79 Million | 1.23 Billion | 1.49 Billion |
Net Income | -321.61 Million | -455.66 Million | 306.12 Million | 130.43 Million | 439.43 Million |
Depreciation & Amortization | 290.22 Million | 197.71 Million | 182.87 Million | 307.1 Million | 369.97 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -1.18 Billion | -1.52 Billion | -544.18 Million | 1.02 Billion | 698.34 Million |
Other non-cash items | 24.66 Million | 11.91 Million | 39.66 Million | -141.76 Million | -40.18 Million |
Investing Cash Flow | -859 Thousand | -273.42 Million | -165.84 Million | 23.84 Million | 132.12 Million |
Investments in PPE | -72.97 Million | -224.21 Million | -107.47 Million | -83.97 Million | -97.57 Million |
Acquisitions | 2.6 Million | 45 Million | 1.76 Million | - | 205.13 Million |
Investment purchases | - | -224.26 Million | -11.2 Million | -203.14 Million | -33.87 Million |
Sales/Maturities of investments | - | 47.7 Million | 50.03 Million | 14 Million | 67.15 Million |
Other Investing Activities | 40.58 Million | -933 Thousand | -47.96 Million | 377.7 Million | -8.72 Million |
Financing Cash Flow | 1.27 Billion | 1.15 Billion | -170.09 Million | -862.48 Million | -688.99 Million |
Debt repayment | -993.95 Million | -1.07 Billion | -176.29 Million | -163.1 Million | -797.47 Million |
Dividends payments | -29.91 Million | -40.67 Million | -39.37 Million | -29.29 Million | -21.57 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 330.55 Million | 99.71 Million | 121.87 Million | 819.84 Million | 380.21 Million |
Other Financing Activities | -2.84 Million | 31.33 Million | 53.48 Million | 180.58 Million | -250.16 Million |
Accounts receivables | -384 Million | 833 Million | -567 Million | -246 Million | 142.79 Million |
Accounts payables | -147.55 Million | -111.29 Million | 205.69 Million | 91.45 Million | -102.04 Million |
Inventory | -1 Billion | -1.81 Billion | -15.68 Million | 1.32 Billion | 730.71 Million |
Other working capital | 264 Million | -347 Million | -117 Million | -490 Million | -73.12 Million |
Cash at beginning of period | 1.05 Billion | 2.03 Billion | 2.36 Billion | 1.96 Billion | 1.02 Billion |
Cash at end of period | 1.21 Billion | 1.05 Billion | 2.03 Billion | 2.36 Billion | 1.96 Billion |
Capital Expenditure | -72.97 Million | -224.21 Million | -107.47 Million | -83.97 Million | -97.57 Million |
Effect of forex changes on cash | 14.61 Million | 31.37 Million | 18.59 Million | 4.15 Million | -4 Million |
Net cash flow / Change in cash | 155.5 Million | -975.77 Million | -334.15 Million | 400.12 Million | 938.19 Million |
Free Cash Flow | -1.2 Billion | -2.1 Billion | -124.27 Million | 1.15 Billion | 1.4 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -19 Million | -321.61 Million | -49 Million | -9 Million | -163 Million | -222 Million |
Depreciation & Amortization | - | 290.22 Million | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -1.18 Billion | - | - | - | - |
Other non-cash items | 19 Million | 24.66 Million | 49 Million | 9 Million | 163 Million | 222 Million |
Investing Cash Flow | - | -859 Thousand | - | - | - | - |
Investments in PPE | - | -72.97 Million | - | - | - | - |
Acquisitions | - | 2.6 Million | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 40.58 Million | - | - | - | - |
Financing Cash Flow | - | 1.27 Billion | - | - | - | - |
Debt repayment | - | -993.95 Million | - | - | - | - |
Dividends payments | - | -29.91 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 330.55 Million | - | - | - | - |
Other Financing Activities | - | -2.84 Million | - | - | - | - |
Accounts receivables | - | -384 Million | - | - | - | - |
Accounts payables | - | -147.55 Million | - | - | - | - |
Inventory | - | -1 Billion | - | - | - | - |
Other working capital | - | 264 Million | - | - | - | - |
Cash at beginning of period | - | 1.05 Billion | - | - | - | - |
Cash at end of period | - | 1.21 Billion | - | - | - | - |
Capital Expenditure | - | -72.97 Million | - | - | - | - |
Effect of forex changes on cash | - | 14.61 Million | - | - | - | - |
Net cash flow / Change in cash | - | 155.5 Million | - | - | - | - |
Free Cash Flow | - | -1.2 Billion | - | - | - | - |
EQX
ORGO
TRUMY
GENTERA
002807
7140